Modalis has been selected as a finalist in the XPRIZE Healthspan FSHD Bonus Prize Competition and awarded research funds.
TOKYO & WALTHAM, Mass.–(BUSINESS WIRE)–Modalis Therapeutics Corporation (Tokyo Stock Exchange: 4883), a pioneering company developing innovative... Read more.
ON24 Authorizes $50 Million Share Repurchase Program
SAN FRANCISCO–(BUSINESS WIRE)–ON24 (NYSE: ONTF), a leading intelligent engagement platform for B2B marketing, today announced that its Board of Directors... Read more.
Techbio Pioneer Etcembly Signs Deal With DJS Antibodies, Part of AbbVie, to Accelerate Antibody Discovery Pipeline
OXFORD, England–(BUSINESS WIRE)–#biotech–British techbio innovator Etcembly has signed a collaboration agreement with DJS Antibodies, a part of... Read more.
Kodiak Gas Services Announces Closing of Sale of Common Stock by Selling Stockholder Pursuant to Rule 144
THE WOODLANDS, Texas–(BUSINESS WIRE)–Kodiak Gas Services, Inc. (NYSE: KGS) (“Kodiak” or the “Company”) today announced the closing of a sale... Read more.
Rosen Law Firm Urges Civitas Resources, Inc. (NYSE: CIVI) Stockholders With Large Losses to Contact the Firm for Information About Their Rights
NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers... Read more.
Securities Fraud Investigation Into Fortrea Holdings Inc. (FTRE) Continues – Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of... Read more.
Dream Unlimited Corp. Reports First Quarter Results
This press release contains forward-looking information that is based upon assumptions and is subject to risks and uncertainties as indicated in the cautionary note... Read more.
Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial Results
Announced capsid license agreement with Lilly to deliver genomic medicines for up to five central nervous system (CNS) disease targets. Received $18 million upfront... Read more.
Building With Resilience Makes Case for Non-Combustible Building Materials as California Rebuilds from Wildfires
Building With Resilience emphasizes that non-combustible construction materials—readily available in California today—offer the best solution for achieving climate,... Read more.
Sangamo Therapeutics Announces Pricing of $23.0 Million Underwritten Offering
RICHMOND, Calif.–(BUSINESS WIRE)–Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the pricing of an underwritten... Read more.